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Diet and Diarrhoea: Which supplements
can be used in community acquired
infectious diarrhoea in children?
Infectious diarrhoea is the most
common cause of diarrhoea worldwide
and is the leading cause of death in
childhood. Many infectious agents
cause diarrhoea (Table 1) and
worldwide rotavirus is the most
common cause of severe diarrhoea
and diarrhoea-related mortality in
children. Despite improvements in
public health and economic wealth in
the developed world, the incidence of
intestinal infections remains high and
continues to be an important clinical
problem. However, gastrointestinal
infections have their major impact in
the developing world.
There have been some major
improvements in our knowledge base
over the past years regarding the
treatment of infectious diarrhoea. Oral
rehydration therapy (ORT) remains
central to case management but
advances have been made by the
introduction of hypotonic solutions and
early evidence on resistant starch
indicates that it may be the substrate
of the future.
Oral Rehydration Therapy (ORT)
Fluid and electrolyte replacement via
the oral route is usually sufficient unless
the person is vomiting and/or fluid
losses are very severe. The scientific
principle and rationale for this therapy
is based on active carrier mediated
sodium-glucose co-t ranspor t .
Recommended oral replacement fluids
are glucose-electrolyte solutions
known collectively as oral rehydration
solutions (ORS). A lower sodium
concentration of 50–60 mmol/l is as
effect ive  as the 90 mmol / l ,
recommended previously the World
Table I: Causes of infectious diarrhoea
Enteropathogen
Viruses
Rotavirus
Enteric adenovirus (types 40, 41)
Calcivirus
Cytomegalovirus
Astrovirus
Bacteria
Vibrio cholera
Enterotoxigenic E coli
Enteropathogenic E coli
Enteroaggregative E coli
Enteroinvasive E coli
Enterohaemorraghic E coli
Shigella spp
Salmonella spp
Campylobacter spp
Yersinia spp
Clostridium difficile
Mycobacterium tuberculosis
Protozoa
Giardia intestinalis
Cryptosporidium parvum
Microsporidia
Isospora belli
Cyclospora cayetanensis
Entamoeba histolytica
Balantidium coli
Helminths
Strongyloides stercoralis
Schistosoma spp
Acute
watery
diarrhoea
usually
resolves
within 5–10
days
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
no
yes
yes
yes
yes
yes
yes
yes
no
no
Dysentery
(Bloody
Diarrhoea)
no
no
no
yes
no
no
no
no
no
yes
yes
yes
yes
yes
yes
yes
yes
no
no
no
no
no
yes
yes
no
yes
Persistent
diarrhoea
with or
without
evidence of
intestinal
malabsorpt
ion
no
no
no
yes
no
no
no
yes
yes
no
no
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
Four main approaches to the treatment of infectious diarrhoea
• Supportive therapy—fluid and electrolyte replacement
• Adults: Symptomatic antidiarrhoeal treatment to reduce stool frequency and any
other symptoms such as abdominal pain
• Adults: Antisecretory drug therapy aimed at reducing faecal losses
• Specific therapy such as antimicrobial chemotherapy to reduce duration and
severity of the illness
Supportive and Supplement Therapy
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Health Organisation (WHO), and
appears to be more efficacious in
reducing faecal losses. In 2002, the
WHO endorsed the use of a low
osmolality ORS (245 mosmol/kg) with
a sodium concentration of 75 mmol/l.
Dehydration occurs more quickly
in infants and young children and
therefore early administration of an
ORS is advised to prevent severe
dehydration and acidosis. In severe
dehydration in infants and young
children, intravenous fluids are advisable.
Epidemiological studies have
shown a distinct negative association
between the frequency and duration
of diarrhoea and physical growth and
development of a child. It is now
generally accepted that early feeding
during diarrhoea decreases severity,
duration and adverse nutritional
sequelae. Food should therefore be
started as soon as the child wishes to
eat  and dr ink normal ly  and
breastfeeding should be continued in
infants. In this regard, prospective
studies are supportive of this practice
and have documented that the severity
and duration of diarrhoeal episodes
are decreased significantly among
infants who continue breastfeeding.
On this basis, recent guidelines have
promoted the continuation of
breastfeeding in infants who develop
diarrhoea.  In view of the above
informat ion and against  the
background of rapid growth in
childhood, historical guidelines, which
encouraged the deliberate withholding
of food resulting in poor intake, are no
longer justified.
Resistant Starch
Although glucose has traditionally
been the main substrate for ORS, the
possibility that the efficacy of ORS
may be increased by using complex
substrates, such as cereals or defined
glucose polymers,  has been
extensively investigated. Replacing
glucose with a glucose polymer such
as rice starch has the advantage of
producing low osmolality solutions
while delivering an increased amount
of substrate in the form of rice starch
polymer along with some protein,
which is also thought to promote active
sodium absorption. Additionally, short-
chain fatty acids are produced in the
colon by the bacterial fermentation of
unabsorbed carbohydrates. Starch
that is resistant to digestion by
amylases in the small intestine
(amylase-resistant starch) is found in
small quantities in many cereals and
is a good substrate for colonic
fermentation. High-amylose maize
starch, obtained from a specific variety
of corn, is rich in resistant starch that
is type 2, a classification based on the
structure and conformation of native
starch molecules. When it is eaten
uncooked, 50 to 70 percent of the
starch is not digested in the small
intestine. Resistant starch is only
partially hydrolysed in the small
intestine and approximately 30%
enters the colon where it is degraded
by colonic bacteria to short chain fatty
acids.  Short-chain fatty acids are a
potent stimulus for the colonic
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absorption of sodium and water from
both the normal and the secreting colon.
A randomised trial in cholera
diarrhoea revealed that a resistant
starch ORS was superior to the
standard therapy (WHO-ORS) and a
rice-flour ORS in its effectiveness in
reducing faecal losses. The time to
the first formed stool in the resistant-
starch group (56.7 18.6 hours) was
significantly shorter than in either the
standard-therapy group (P=0.001) or
the rice-flour group (P=0.05). The loss
of fluid in stools was considerably
reduced, when resistant starch was
administered in addition to the
standard oral rehydration solution and
when children were encouraged to
eat as soon as possible after the
administration of the solution.
The use of cereal-based oral
rehydration therapy in patients with
cholera and rice-derived glucose
polymer in infants with diarrhoea
(predominantly those with rotavirus
infection) has been reported to
significantly reduce stool output.
These clinical benefits are thought to
stem from the increased absorption
of sodium and water. Although the
hypo-osmolality of cereal-based
solutions has been considered critical
to the absorption of sodium and water,
other possible contributory factors
include the enhancement of mucosal
repair by luminal nutrients and a
specific antisecretory factor in rice. It
is possible that some of these effects
may contribute to the benefit of
amylase-resistant starch, because
some of the starch is digested in the
small intestine.
Diarrhoea is thought to increase
zinc losses and the same is true of
vitamin A.  In the presence of an
inadequate dietary intake, such losses
may further impair zinc nutriture and
contribute to zinc deficiency and its
consequences in terms of growth and
development.
Zinc supplements added to
conven-tional anti-diarrhoeal therapy
have been reported to be effective in
reducing the duration of acute and
persistent diarrhoea in developing
countries. In this regard, pooled
analysis of 10 clinical trials from 9
developing countries indicate that zinc-
supplemented children had a 15%
lower probability of continuing
diarrhoea in the acute diarrhoea trials,
a 24% lower probability of continuing
diarrhoea and a 42% lower rate of
treatment failure or death in the
persistent diarrhoea trials. The pooled
analyses included randomised trials,
which provided supplements
containing at least one halve of the
US Recommended Daily Allowances
(RDA) for children (3 -10 mg elemental
zinc). The study populations included
in the pooled analysis varied widely
in background characteristics and
nutritional status. The beneficial effects
of zinc supplements in diarrhoeal
morbidity were accompanied by an
increase in plasma zinc concentrations
in the zinc- supplemented children,
with a decrease or no change in the
plasma zinc concentrations in the
control non-supplemented group.
More recently, other investigators had
confirmed these beneficial effects.
These f indings indicate that
interventions to improve zinc intake
deserve more attention as means to
improve child health. Zinc deficiency
during childhood, contributes to
stunting and is associated with an
increased incidence and prevalence
of infectious diarrhoea. Supplemen-
tation at RDA levels has been shown
to improve these clinical conditions,
with children who are zinc-deficient
deriving the greatest benefit .
Therefore, supplementing with zinc
may be considered doubly beneficial
in improving child health. Irrespective,
due care should be exercised with
any such supplements in view of the
findings of a significantly (p  = 0.03)
higher mortality (primarily due to
sepsis) among severely malnourished
children receiving higher doses of zinc
supplements [2 fatalities in the low
dose supplementation group (1.5
mg/kg zinc, as zinc sulphate) daily for
15 days followed by placebo for 15
days vs. 17 fatalities combined in the
groups receiving higher zinc doses (6
mg/kg) for 15 days followed by place-
bo for 15 days or 6 mg/kg for 30 days].
With regard to vitamin A, fever is
known to increase the urinary excretion
of the vitamin and vitamin A status is
adversely affected by the frequency
and  dura t i on  o f  d ia r rhoea .
Nevertheless, the data relating to the
effect of high dose vitamin A
supplements on the frequency and/or
severity of infections is variable and
needs to be better defined. In Ghana
for instance, vitamin A supplemen-
tation did not significantly affect the
prevalence of diarrhoea and respira-
tory infections, despite the fact that
children who received the supple-
ments attended health clinics less
frequently and had fewer hospital
admissions. Similar findings have been
reported from Brazil regarding the
frequency of hospitalisation and the
prevalence of pneumonia, despite the
concomitant reduction in the number
of diarrhoeal stools and episodes of
severe diarrhoea. Of further interest is
the more recent trial in Tanzania, which
reported a significant (44%) reduction
in severe watery diarrhoea during the
year after discharge among children
admitted to hospital with pneumonia
who received vitamin A supplements
as compared with those who received
placebo.
Lactobacillus rhamnosus GG and
Lactobacillus reuteri has been
repeatedly shown to reduce the
duration of acute infantile diarrhoea,
often the result of infection with
rotavirus, by about 50%. This strain
The available evidence is strongly supportive of zinc deficiency, as measured by
plasma zinc concentrations, being associated with an increased risk of diarrhoea. (the
human body contains 2–4 g of zinc, but in the plasma, zinc only occurs in a concentration
of 12–16 µmol/L) The substantial benefits of zinc supplementation in the prevention
of diarrhoea, one of the leading causes of death in children in developing countries,
suggest that zinc supplements may be an important contributory means to improving
child survival
Zinc, vitamin A and diarrhoea in infants and children:
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has also been useful as a prophylaxis
of diarrhoea in undernourished
children, especially in infants who are
not breastfed. The underlying mecha-
nism is thought to be the stimulation
of the immune response and/or
enhancement of mucosal integrity.
Bifidobacterium bifidum, given in
conjunction with Streptococcus
thermophilus in standard milk formula,
has also been shown to reduce the
incidence of rotaviral diarrhoea. Other
studies in children with gastroenteritis
who received a probiotic supplement
(either Lactobacillus rhamnosus,
Lactobacillus reuteri or Lactobacillus
casei) have documented a significant
decrease in the duration of diarrhoea
in the children studied. It should
however, be borne in mind that
although probiotics are consumed as
food(s) by many children, and the
tolerance and safety of long-term
consumption of specific types and
strains of bacteria is being increasingly
documented, on a cautionary note
such foods/supplements should not
be consumed by sick children without
medical supervision.
Conclusions and recommen-
dations:
• Fluid and electrolyte replacement
via the oral route is usually sufficient
unless the person is vomiting
and/or fluid losses are large and
sustained. ORT has been a life
saving therapy for many children
with severe diarrhoea.
• Studies in which children with
cholera- induced diarrhoea
consumed resistant starch plus the
usual hydration therapy showed a
major reduction in fluid loss and
time of recovery
• Food should be started as soon
as the child wishes to eat and drink
normally. Feeding with cooked rice,
a source of resistant starch has
been found to reduce the severity
of diarrhoeal disease with a
reduction on mortality.
• Breastfeeding should be continued
in infants.
• During childhood, zinc deficiency
contributes to stunting and is
associated with an increased
incidence and prevalence of
infectious diarrhoea. Supplemen-
tation at RDA levels has been
shown to improve these clinical
conditions, with children who are
zinc deficient deriving the greatest
benefit. The role of vitamin A in the
prevention and treatment of diar-
rhoea needs to be better defined.
• A supplement providing the RDA
for zinc may be necessary when
dietary intake is not adequate and
or the intake of phytic acid is very
high in the diet. Higher dose supple-
ments should best be avoided.
• Probiotics have been shown to be
effective in the treatment of acute
infectious diarrhoea in children,
prevention of antibiotic associated
diarrhoea, prevention of noso-
comial and community acquired
diarrhoea in children. As a general
rule, probiotics (foods or supple-
ments) in sick children should be
consumed under medical super-
vision.
For further, personalised and
more detailed information,
please contact NICUS or a
dietitian registered with the
Health Professions Council of
South Africa
References from the scientific literature
used to compile this document are
available on request. 
Probiotics have been shown to be effective in the treatment of acute infectious diarrhoea
and in the prevention of nosocomial and community acquired diarrhoea in children.
The full clinical implications of the role of probiotics in the prevention of diarrhoea must
however be more comprehensively documented.  Nevertheless, greater clinical
experience is necessary before the use of probiotics becomes an accepted practice.
Probiotic Supplements:
